IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
556.93
+11.07 (2.03%)
Aug 21, 2026, 4:00 PM EDT - Market closed

IDEXX Laboratories Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,5534,3043,8983,6613,3673,215
Revenue Growth
12.77%10.42%6.46%8.72%4.73%18.80%
Gross Profit
2,8432,6602,3792,1902,0041,889
Operating Income
1,4681,3601,1901,097898.77932.03
Net Income
1,1401,059887.87845.04679.09744.85
Earnings Per Share
14.2213.0810.6710.068.038.60
EPS Growth
18.41%22.59%6.06%25.28%-6.63%28.17%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
IDEXX VetLab Consumables
1,6201,4971,3031,1881,0571,007
Rapid Assay Products
351.19348.95359.75344.49313.67296.85
Reference Laboratory Diagnostic & Consulting
1,5051,4241,3361,2791,1781,124
CAG Diagnostics Services & Accessories
142.11137.42130.37124.05111.26107.27
CAG Diagnostics Capital - Instruments
199.24200.21131.93137.6147.33149.14
Veterinary Software, Services & Diagnostics
366.1345.88312.62279.33251.19206.26
Water Segment
213.66201.15185.11168.15155.72146.51
LPD Segment
139.09131.79122.06121.66122.61135.89
Other
17.1817.4816.2918.7930.243.01
Revenue (Total)
4,5534,3043,8983,6613,3673,215

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
196.93180.07288.27453.93112.55144.45
Total Debt
1,096976.51986.951,0671,4701,031
Net Cash (Debt)
-899.15-796.44-698.68-613.42-1,357-886.56
Net Cash Growth
------
Net Cash Per Share
-11.22-9.83-8.39-7.30-16.05-10.24

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,3721,182929906.51542.98755.55
Capital Expenditures
-117.18-124.68-120.92-133.63-148.84-119.55
Free Cash Flow
1,2541,057808.08772.88394.15636
Free Cash Flow Growth
59.92%30.82%4.55%96.09%-38.03%17.54%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.45%61.80%61.04%59.82%59.52%58.76%
Operating Margin
32.23%31.60%30.53%29.97%26.69%28.99%
Pretax Margin
31.28%30.77%28.48%28.99%25.54%28.07%
Profit Margin
25.03%24.62%22.78%23.08%20.17%23.16%
FCF Margin
27.55%24.56%20.73%21.11%11.71%19.78%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
39.1650.9938.1354.5549.7574.96
Forward PE
35.5548.0335.3551.9344.2573.77
P/FCF Ratio
34.9851.1041.9059.6485.7287.79
PS Ratio
9.6412.558.6912.5910.0317.36